We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry. By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.
With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
.png)
Scipio bioscience is an early-stage company that develops innovative solutions for single-cell sample preparation and data analysis to answer the growing needs of basic and clinical research labs. Its patented technology is based on an innovative chemical approach conceived by its President and Co-Founder, Prof Stuart Edelstein, a world-renowned biophysicist. The recently launched Asteria© single-cell RNA-seq kit is the first kit of a range of products to provide complete solutions in single-cell sample preparationScipio bioscience is an early-stage company that develops innovative solutions for single-cell sample preparation and data analysis to answer the growing needs of basic and clinical research labs. Its patented technology is based on an innovative chemical approach conceived by its President and Co-Founder, Prof Stuart Edelstein, a world-renowned biophysicist. The recently launched Asteria© single-cell RNA-seq kit is the first kit of a range of products to provide complete solutions in single-cell sample preparation.
Whether you are looking for that rare specific antibody producing B-cell or hybridoma, selecting high producing clones from your large starting population of transfected CHO cells, identifying single genome edited cells, performing CAR-T cell research, or a wide range of other single cell based research projects, Sphere Fluidics core picodroplet technology makes it possible. Sphere Fluidics’ renowned robust and easy to use industrial and research picodroplet-based platforms enable faster, less costly and more effective sample screening and biologics discovery.
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single-cell sequencing. Single-cell sequencing has already enabled ground breaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. At Parse Biosciences, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease.
Dolomite Bio (a brand of the Blacktrace group of companies) creates innovative products for high throughput single cell research. By encapsulating single cells in microfluidic droplets, our products enable rapid analysis of thousands or millions of individual cells and their biological products.
Benefits of Dolomite Bio systems:
I&L Biosystems launches revolutionary single cell technology across Europe:
New microfluidics-based personal cell sorters are the ultimate solution for individual labs looking to easily separate cells that researchers could not previously isolate without triggering biological changes that ruin experiments. The cartridge technology is safe and sterile, eliminating the need for instrument maintenance. Single-cell dispensing capability can be added.
Meet I&L and the all new Wolf-2 from NanoCellect.
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies to advance cell based assays that are affordable, compact, and easy-to-use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, CRISPR and basic research.
